| Product Name | MF | CAS | Details |
|---|
| (endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide | C20H30BrNO3 | 58073-59-9 | Details |
| ATROPINE METHYL BROMIDE | C18H26BrNO3 | 2870-71-5 | Details |
| Ethyl alpha-Formyl Benzeneacetic Acid Ester | C11H12O3 | 17838-69-6 | Details |
| Tropic acid | C9H10O3 | 529-64-6 | Details |
| ATP-M1;Benzeneacetic acid, α-formyl-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester | C17H21NO3 | 22226-37-5 | Details |
| 1,2-dimethylpiperidine | C7H15N | 671-36-3 | Details |
| Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-6,8-dithioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl- | C21H15F4N5OS2 | 2649802-40-2 | Details |
| Benzoic acid, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-, methyl ester | C21H14F4N4O3S | 1950587-19-5 | Details |
| APLA-M2-COOH | C12H12FNO4 | 2819997-98-1 | Details |
| AP-417 | C52H79NO14 | 1237826-25-3 | Details |
| AP-2S-CN | C13H14FN3O | 915087-26-2 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| 2,6-Piperidinedione, 3-[1,3-dihydro-4-(hydroxyamino)-1-oxo-2H-isoindol-2-yl]- | C13H13N3O4 | 2717380-87-3 | Details |
| 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | C13H11N3O5 | 827026-45-9 | Details |
| Noratropine | C16H21NO3 | 16839-98-8 | Details |
| APOATROPINE | C17H21NO2 | 500-55-0 | Details |
| Ethyl Tropic Acid | C11H14O3 | 3979-14-4 | Details |
| METHOXY-PHENYL-ACETIC ACID METHYL ESTER | C10H12O3 | 3558-61-0 | Details |
| Atropine Impurity 5 | C18H25NO2 | 88607-15-2 | Details |
| Ipratropium Bromide EP Impurity F Bromide | C20H28BrNO2 | 60018-35-1 | Details |
| YB-ZZF;IpratropiuM BroMide IMpurity F (Mixture of DiastereoMers) | C20H29Br2NO3 | 17812-46-3 | Details |
| YB-S2-COOH;Anisodine Impurity 4 | C9H8O3 | 59216-85-2 | Details |
| 3-methoxy-3-oxo-2-phenylpropanoic acid | C10H10O4 | 33315-63-8 | Details |
| DL-TROPIC ACID | C9H10O3 | 552-63-6 | Details |
| 8-isopropyl-8-azabicyclo[3.2.1]octan-3-one | C10H17NO | 3423-28-7 | Details |
| EP-E;IpratropiuM BroMide IMpurity E | C19H27NO3 | 183626-76-8 | Details |
| Ipratropium bromide monohydrate | C20H32BrNO4 | 66985-17-9 | Details |
| 2-Pyridinecarboxamide, 1,4-dihydro-N-methyl-4-oxo- | C7H8N2O2 | 1061231-84-2 | Details |
| Regorafenib Impurity 13 | C14H14N2O | 2909-32-2 | Details |
| N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-(4-hydroxyphenyl)urea | C14H10ClF3N2O2 | 1129683-83-5 | Details |
| Benzene, 2-chloro-4-isocyanato-1-(trifluoromethyl)- | C8H3ClF3NO | 39893-50-0 | Details |
| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide | C20H19N5O3 | 2004659-83-8 | Details |
| Urea, N'-[4-chloro-3-(trifluoromethyl)phenyl]-N,N-dimethyl- | C10H10ClF3N2O | 2711-18-4 | Details |
| Acetamide,N-(2-fluoro-4-hydroxyphenyl)- | C8H8FNO2 | 103842-00-8 | Details |
| N-methyl-4-phenoxypyridine-2-carboxamide | C13H12N2O2 | 2004659-85-0 | Details |
| 4-bromo-N-methylpicolinamide | C7H7BrN2O | 1209459-88-0 | Details |
| SL-M2-TA-COOH;4-phenoxypyridine-2-carboxylic acid | C12H9NO3 | 99970-10-2 | Details |
| 2-CHLORO-6-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 16583-76-9 | Details |
| 2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL | C8H3ClF3NO | 51488-22-3 | Details |
| 2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid | C14H11NO5 | 376591-94-5 | Details |
| 2-HYDROXY-3''-NITRO-BIPHENYL-3-CARBOXYLIC ACID | C13H9NO5 | 376591-95-6 | Details |
| 3-(2-Hydroxyphenyl)benzoic acid | C13H10O3 | 893736-72-6 | Details |
| S2-Z01 | C14H18N2O | 2500321-37-7 | Details |
| Levosimendan | C14H12N6O | 141505-33-1 | Details |
| 6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | C11H13N3O | 36725-28-7 | Details |
| (R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | C11H13N3O | 101328-85-2 | Details |
| (S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl- | C11H13N3O | 101328-84-1 | Details |
| NA | Details |
| LevosiMendan iMpurity | 139052-02-1 | Details |
| Levosimendan Impurity 14 | C14H12N6O | 144238-75-5 | Details |
| diethyl 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonate | C18H23NO6 | 81937-39-5 | Details |
| 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonic acid | C14H15NO6 | 1221499-54-2 | Details |
| Levosimendan Impurity 4 | C14 H14 N6 O2 | 131741-37-2 | Details |
| Levosimendan Impurity 8 | C14H14N6O2 | 274263-65-9 | Details |
| 3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-phenyl-, (5R)- | C11H12N2O | 1630760-89-2 | Details |
| Levosimendan Impurity 16 | C11H12N2O | 2290570-69-1 | Details |
| Levosimendan-001 | C11H14N4O | 244077-42-7 | Details |
| Levosimendan Impurity 2 | C11H12N2O2 | 103416-88-2 | Details |
| Levosimendan Impurity 10 | C11H12N2O2 | 134678-47-0 | Details |
| 4-(4-Aminophenyl)-3-methyl-4-oxobutanoic acid | C11H13NO3 | 42075-29-6 | Details |
| Propanedinitrile, 2-[2-[4-(1,6-dihydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]- | C14H10N6O | 131741-36-1 | Details |
| N-[4-(2-bromopropanoyl)phenyl]acetamide | C11H12BrNO2 | 63514-63-6 | Details |
| 4-(4-acetamidophenyl)-3-methyl-4-oxobutanoic acid | C13H15NO4 | 36725-26-5 | Details |
| 3(2H)-Pyridazinone, 6-(4-chlorophenyl)-4,5-dihydro-5-methyl-, (5R)- | C11H11ClN2O | 1630760-90-5 | Details |
| Levosimendan | C11H11ClN2O | 36725-41-4 | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| N-[4-(AMinocarbonyl)-3-fluorophenyl]-2-Methylalanine | C11H13FN2O3 | 1242137-20-7 | Details |
| D3-EZLA-S1 | C13H16FNO4 | 1802242-47-2 | Details |
| Thiourea, N-[4-cyano-3-(trifluoromethyl)phenyl]- | C9H6F3N3S | 1415552-04-3 | Details |
| Enzalutamide Impurity 7 | C21H18F4N4O3S | 2030242-21-6 | Details |
| NA | 1489977-24-8 | Details |
| EZLA-2JXA | C22H18F4N4O2S | 1443331-78-9 | Details |
| 4-CYANO-3-(TRIFLUOROMETHYL)ACETANILIDE | C10H7F3N2O | 97760-99-1 | Details |
| 4-(Isopropylamino)-2-(trifluoromethyl)benzonitrile | C11H11F3N2 | 864286-45-3 | Details |
| 2-fluoro-N,N-dimethyl-4-nitro-benzamide | C9H9FN2O3 | 1187368-66-6 | Details |
| Benzamide, N-[[[4-cyano-3-(trifluoromethyl)phenyl]amino]thioxomethyl]- | C16H10F3N3OS | 1895865-08-3 | Details |
| EZ-437 | C21H19F4N3O3 | 2463603-98-5 | Details |
| 2-fluoro-4-hydroxy-N-methylbenzamide | C8H8FNO2 | 1243392-80-4 | Details |
| API-ZA05/API-ZA05/RG-F | C21H16F4N4O3 | 2188236-16-8 | Details |
| Regorafenib Impurities67 | C16H16FN3O4 | 2514957-39-0 | Details |
| Methyl (4-chloro-3-trifluoromethylphenyl)carbamate | C9H7ClF3NO2 | 19448-54-5 | Details |
| Regorafenib impurity | C14H9ClF4N2O2 | 2243399-56-4 | Details |
| INDEX NAME NOT YET ASSIGNED | C22H12Cl2F7N3O3 | 2518416-73-2 | Details |
| RG-491; INDEX NAME NOT YET ASSIGNED | C25H19F2N5O4 | 2518234-85-8 | Details |
| API-ZA07;3,4-BIS CTF- CARBOMYLAMINE PMA REGORAFENIB | C35H23Cl2F7N6O5 | 2098799-13-2 | Details |
| N-Desmethyl Regorafenib N-Oxide (M5 Metabolite) | C20H13ClF4N4O4 | 835621-12-0 | Details |
| Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate | C17H19N3O4 | 2206827-14-5 | Details |
| Sorafenib Impurity 6 | C27H23N5O6 | 2204442-52-2 | Details |
| M2 | C25H22N4O4 | 1902123-70-9 | Details |
| EltroMbopag Methyl Ester | C26H24N4O4 | 1246929-01-0 | Details |
| Eltrombopag Impurity 1 | C25H23N5O3 | 1246929-02-1 | Details |
| M1 | C13H11NO3 | 376592-93-7 | Details |
| M1-ZA01 | 1418987-67-0 | Details |
| M2-ZA05 | C25H21ClN4O4 | 376592-56-2 | Details |
| [1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[1-(3,4-dimethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]diazenyl]-2'-hydroxy-, 2-aminoethyl ester | C27H27N5O4 | 2587607-84-7 | Details |
| 1437383-35-1 | C26H24N4O4 | 1437383-35-1 | Details |
| AQ-M1-JM | C14H13NO3 | 1176777-76-6 | Details |
| 1-Bromo-2-methoxy-3-nitro-benzene | C7H6BrNO3 | 98775-19-0 | Details |
| 2-Fluoro-4-Hydroxyaniline | C6H6FNO | 1009816-75-4 | Details |
| RG-368;Regorafenib Impurity 10 | C19H17FN4O3 | 2098799-12-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||